Ablexis Announces License Agreement with Adimab
09 Feb 2023 //
BUSINESSWIRE
Ablexis and AlivaMab Services Announce Expansion of Antibody Drug Discovery
14 Nov 2022 //
BUSINESSWIRE
Ablexis & AlivaMab Discovery Services Announce Agreements with Almirall
31 Jan 2022 //
BUSINESSWIRE
Ablexis, AlivaMab Discovery Services,& Berkeley Lights Collab to Anti-SARS-CoV-2
22 Apr 2020 //
PR NEWSWIRE